Research Article

Intestinal Lymphatic Delivery of Praziquantel by Solid Lipid Nanoparticles: Formulation Design, In Vitro and In Vivo Studies

Table 2

Formulation composition and the effect of different formulation variables on particle size (PS), polydispersity index (PI), zeta potential (ZP), entrapment efficiency (EE), and drug loading (DL).

Code LipidSurfactantLSC
(%w/v)
HSC
(%w/v)
LC
(%w/v)
DC
(%w/v)
PS (nm)PIZP (−mV) EE (%)DL (%)

F1TPP1880.52.05.00.1
F2TPP1881.02.05.00.1
F3TPP1881.52.05.00.1
F4TPP1882.02.05.00.1
F5TPP1882.52.05.00.1
F6TPP1881.51.05.00.1
F7TPP1881.51.55.00.1
F8TPP1881.52.05.00.1
F9TPP1881.52.55.00.1
F10TPP1881.53.05.00.1
F11TPP1881.52.01.00.1
F12TPP1881.52.02.50.1
F13TPP1881.52.05.00.1
F14TPP1881.52.05.00
F15TPP1881.52.05.00.025
F16TPP1881.52.05.00.05
F17TPP1881.52.05.00.1
F18TPP1881.52.05.00.2
F19TPP1881.52.05.00.1
F20TSP1881.52.05.00.1
F21TMP1881.52.05.00.1
F22TPTw801.52.05.00.1
F23TPP4071.52.05.00.1
F24TPP1881.52.05.00.1
F25TPP1882.02.55.00.05
F26TSP1882.02.55.00.05